Close Menu

NEW YORK — Scipio Bioscience said on Tuesday that it has raised €6.0 million ($6.5 million) in Series A financing.

The round was led by M Ventures, the venture capital arm of Merck KGaA. It also included existing investors Seventure Partners' Quadrivum I and High-Tech Gründerfonds, as well as new investors Financière Arbevel and Investiere.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.